JP2004502653A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502653A5
JP2004502653A5 JP2002503320A JP2002503320A JP2004502653A5 JP 2004502653 A5 JP2004502653 A5 JP 2004502653A5 JP 2002503320 A JP2002503320 A JP 2002503320A JP 2002503320 A JP2002503320 A JP 2002503320A JP 2004502653 A5 JP2004502653 A5 JP 2004502653A5
Authority
JP
Japan
Prior art keywords
composition according
candida albicans
vaccine
measurement
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002503320A
Other languages
English (en)
Japanese (ja)
Other versions
JP4933714B2 (ja
JP2004502653A (ja
Filing date
Publication date
Priority claimed from AUPQ8214A external-priority patent/AUPQ821400A0/en
Priority claimed from AUPQ8294A external-priority patent/AUPQ829400A0/en
Application filed filed Critical
Priority claimed from PCT/AU2001/000725 external-priority patent/WO2001097836A1/en
Publication of JP2004502653A publication Critical patent/JP2004502653A/ja
Publication of JP2004502653A5 publication Critical patent/JP2004502653A5/ja
Application granted granted Critical
Publication of JP4933714B2 publication Critical patent/JP4933714B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002503320A 2000-06-19 2001-06-19 カンジダ症の治療のための組成物および方法 Expired - Fee Related JP4933714B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPQ8214 2000-06-19
AUPQ8214A AUPQ821400A0 (en) 2000-06-19 2000-06-19 Composition and methods for treatment of candidiasis
AUPQ8294A AUPQ829400A0 (en) 2000-06-22 2000-06-22 Compositions and methods for treatment of candidiasis
AUPQ8294 2000-06-22
PCT/AU2001/000725 WO2001097836A1 (en) 2000-06-19 2001-06-19 Compositions and methods for treatment of candidiasis

Publications (3)

Publication Number Publication Date
JP2004502653A JP2004502653A (ja) 2004-01-29
JP2004502653A5 true JP2004502653A5 (https=) 2008-08-14
JP4933714B2 JP4933714B2 (ja) 2012-05-16

Family

ID=25646360

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002503320A Expired - Fee Related JP4933714B2 (ja) 2000-06-19 2001-06-19 カンジダ症の治療のための組成物および方法

Country Status (10)

Country Link
US (1) US7655248B2 (https=)
EP (1) EP1303300B1 (https=)
JP (1) JP4933714B2 (https=)
KR (1) KR20030016298A (https=)
CN (2) CN1443075A (https=)
AT (1) ATE476987T1 (https=)
BR (1) BR0111785A (https=)
CA (1) CA2411912C (https=)
DE (1) DE60142786D1 (https=)
WO (1) WO2001097836A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146411A (en) * 1998-12-24 2000-11-14 Alsius Corporation Cooling system for indwelling heat exchange catheter
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
CA2577165C (en) * 2004-08-17 2015-01-27 Hunter Immunology Pty Limited Oral killed vaccines and method for providing same
EP1723965A1 (en) 2005-05-18 2006-11-22 Stallergenes Sa Compositions for antigen-specific induction of immuno-tolerance via oral immunization
WO2009013972A1 (ja) * 2007-07-24 2009-01-29 Dainichiseika Color & Chemicals Mfg. Co., Ltd. 免疫アジュバント及びＩｇＡ抗体測定方法
US9180173B2 (en) * 2013-12-09 2015-11-10 Stephanie D. Neider Methods of treating psoriasis using candida antigen
FR3048361B1 (fr) * 2016-03-01 2020-12-18 Biose Compositions pour le traitement des candidoses
CN106635849A (zh) * 2016-11-15 2017-05-10 河北工程大学 一种白色念珠菌感染鸡模型建立的方法
US11273190B2 (en) * 2019-05-06 2022-03-15 Kenda Rigdon Composition of heat-killed yeast and taurine or a phytomedicine for the treatment of chronic inflammation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397839A1 (fr) * 1977-07-18 1979-02-16 Grimberg Georges Compose donnant un vaccin oral intestinal
CH680192A5 (https=) * 1989-12-13 1992-07-15 Nestle Sa
JP3510639B2 (ja) * 1991-06-28 2004-03-29 カルピス株式会社 インターロイキン産生能を調節する機能を持たせた機能性食品又は健康食品
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
US5811249A (en) * 1994-10-21 1998-09-22 University Of Utah Research Foundation Control of infectious microorganisms by modulation of chorionic gonadotropin-related protein activity
US5661377A (en) 1995-02-17 1997-08-26 Intraop Medical, Inc. Microwave power control apparatus for linear accelerator using hybrid junctions
JPH09110707A (ja) * 1995-10-12 1997-04-28 Wakamoto Pharmaceut Co Ltd 慢性腎不全改善剤および透析患者のクオリティー オブ ライフ改善剤
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US5858378A (en) * 1996-05-02 1999-01-12 Galagen, Inc. Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
EP0834322A3 (en) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine
JPH10139674A (ja) * 1996-11-11 1998-05-26 Yakult Honsha Co Ltd インターロイキン１２産生促進剤
US5869290A (en) * 1996-11-21 1999-02-09 Smithkline Beecham Corporation Cayae1 polynucleotides
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
ATE207755T1 (de) * 1998-04-30 2001-11-15 Vesely Renata Maria Cavaliere Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
US20020009429A1 (en) * 1999-01-29 2002-01-24 Galagen, Inc. Pharmaceutical composition comprising a selected antigen and candida species antigen and methods

Similar Documents

Publication Publication Date Title
van Houte et al. Ecology of human oral lactobacilli
Adachi et al. Effect of professional oral health care on the elderly living in nursing homes
Yoneyama et al. Oral care and pneumonia
Kang et al. Pluronic® F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin
De Vrese et al. Probiotics and non-intestinal infectious conditions
Russell et al. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
CN113144002B (zh) 一种维持口腔健康的益生菌组合物及其应用
AU2002335001A1 (en) Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
JP2003535903A (ja) プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
JP2004502653A5 (https=)
CN102604854B (zh) 新颖乳酸菌株及其调节免疫反应的用途
CN116904341A (zh) 一株可改善口腔健康的鼠李糖乳杆菌及其益生菌组合物
UA97078C2 (uk) Фармацевтична композиція інгібітора протонної помпи і пребіотика для лікування виразкових уражень шлунка й дванадцятипалої кишки
Van Winkelhoff et al. Long-standing bacteremia caused by oral Actinobacillus actinomycetemcomitans in a patient with a pacemaker
Heidmann et al. Rhodococcus equi pneumonia: clinical findings, diagnosis, treatment and prevention
CN114574405B (zh) 植物乳杆菌菌株wka86及其在制备防治口臭制品方面的用途与制品
EP1300472A1 (en) A method for testing the effect of nutrients on gastrointestinal colonisation resistance of humans
TW201200162A (en) Lactobacillus salivarius for improving oral bacterial groups and health care compositions thereof
JP2003527432A (ja) 腹膜炎の治療のための乳酸菌の使用
US7655248B2 (en) Compositions and methods for treatment of candidiasis
JP5108068B2 (ja) 口腔内の細菌群を改善するラクトバシラス・ファーメンタムＳＧ−Ａ９５（ＬａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍＳＧ−Ａ９５）及びその保健組成物
RU2602692C1 (ru) Способ лечения хронического фарингита
Huang Asthma and diabetes
CN113893267B (zh) 嗜酸乳杆菌La28在抗流感病毒中的新应用
Sahni Pulmonary moniliasis